Skip to content
CompanySight
Company No. 07112415 · Incorporated 23 Dec 2009

Integrated Pharmaceutical Services (Ips) Limited

Registered name: INTEGRATED PHARMACEUTICAL SERVICES (IPS) LIMITED

Part of Ipsco Limited group

Integrated Pharmaceutical Services (Ips) Limited made £0 revenue and £0 profit in the year to 28 Feb 2025. read from filing text

Integrated Pharmaceutical Services (Ips) Limited’s revenue was £0 in the year to 28 Feb 2025, with £0 profit and 0 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in West Molesey; we hold 4 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21200Manufacture of pharmaceutical preparations
Status
Active
Location
West Molesey, London
Age
16 yrs · since 2009
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company's ultimate and immediate parent undertaking is IPSCO Limited, a company registered in England and Wales. The smallest and largest group to consolidate these financial statements is IPSCO L”

Latest accounts · year to 28 Feb 2025

Key figures

Small team
Revenue
£0
Growth —
Profit
£0
Growth ▼100%
Profit margin
—
 
Employees
0
Change —
Profit / employee
—
 
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to28 Feb 202228 Feb 202328 Feb 202428 Feb 2025
DisclosureFull P&Lread from filing textFull P&Lread from filing textFull P&Lread from filing textFull P&Lread from filing text
Profit & loss
Revenue (turnover)£0£0£0£0
Profit before tax−£224k£0£248k£0
Profit after tax−£224k£0£248k£0
Profit (best available)−£224k£0£248k£0
Employees (average)0000
Ratios
Profit margin————
Growth (year on year)
Profit growth———▼100%
Balance sheet — indirect signals, not revenue
Net assets−£19m−£19m−£18.7m−£18.7m
Debtors£1£1£1£1
SourceFullAccounts · bulk data Jan 2024FullAccounts · bulk data Jan 2024FullAccounts · bulk data Jun 2024FullAccounts · bulk data Jul 2025
Derived from the latest filing

How the business works

Profit margin
—
Profit ÷ revenue.
Gross margin
—
Gross profit ÷ revenue. High for software and services.
Revenue per employee
—
Revenue ÷ average employees.
Profit per employee
—
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
—
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now −£18.7m
Cash at bank
—
Now —
Headcount
—
Now 0
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Ipsco Limitedultimate parent75–100%
  2. Integrated Pharmaceutical Services (Ips) Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (1)

Sister companies (1)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 28 Feb 2025 (profit £0), from the Companies House accounts bulk data published Jul 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.